Design Therapeutics, Inc.
DSGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $349,143 | $148,359 | $571,559 | $983,575 |
| - Cash | $22,563 | $21,200 | $26,500 | $298,569 |
| + Debt | $2,334 | $3,050 | $3,691 | $3,633 |
| Enterprise Value | $328,914 | $130,209 | $548,750 | $688,639 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$596 | -$537 | -$466 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$48,992 | -$66,325 | -$62,842 | -$35,702 |
| % Margin | – | – | – | – |
| Net Income | -$49,588 | -$66,862 | -$63,308 | -$35,533 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.88 | -1.19 | -1.14 | -0.77 |
| % Growth | 26.1% | -4.4% | -48.1% | – |
| Operating Cash Flow | -$43,105 | -$58,560 | -$51,317 | -$29,377 |
| Capital Expenditures | -$340 | -$256 | -$918 | -$1,538 |
| Free Cash Flow | -$43,445 | -$58,816 | -$52,235 | -$30,915 |